Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients

被引:0
|
作者
Jian Yu Xu
Qing Hong Dan
Vivian Chan
Nelson M S Wat
Sidney Tam
Sau Cheung Tiu
Ka Fai Lee
Shing Chung Siu
Man Wo Tsang
Lai Ming Fung
Kin Wah Chan
Karen S L Lam
机构
[1] University of Hong Kong,Department of Medicine
[2] Queen Mary Hospital,Clinical Biochemistry Unit
[3] University of Hong Kong,Department of Medicine
[4] Queen Mary Hospital,Department of Medicine
[5] Queen Elizabeth Hospital,Department of Medicine
[6] Kwong Wah Hospital,Department of Medicine
[7] Tung Wah Eastern Hospital,Department of Medicine
[8] United Christian Hospital,Department of Medicine
[9] Caritas Medical Centre,undefined
[10] Princess Margaret Hospital,undefined
来源
关键词
maturity-onset diabetes of the young; obesity; insulin resistance; Chinese;
D O I
暂无
中图分类号
学科分类号
摘要
In Caucasians, maturity-onset diabetes of the young (MODY) is mostly caused by mutations in the hepatocyte nuclear factor (HNF)-1α (MODY3) and glucokinase (MODY2) genes. Most Japanese MODY patients, however, are not linked to known MODY genes. In this study, we examined the genetic and clinical characteristics of Chinese subjects with MODY. The study included 146 unrelated families fulfilling the minimum criteria for MODY: two consecutive generations of type II diabetes with at least one member diagnosed under the age of 25. We screened for mutations in the HNF-4α (MODY1), MODY2 and MODY3 genes by direct sequencing. Antibody to glutamic acid decarboxylase (GAD-Ab) was measured in subjects with MODY of unknown cause (MODYX). Insulin resistance index and other clinical data were compared in sex-, age- and duration-matched MODY3 and MODYX patients. In all, 13 families had MODY3 mutations and two had MODY2 mutations. No MODY1 mutation was found. Four of the 12 different MODY3 mutations were newly identified novel mutations (Q243E, A311D, P379R and P488fsdelC). In subjects with MODYX, 3% were GAD-Ab positive and 60% were overweight. Compared to MODY3 patients, MODYX patients had higher body mass index (P<0.02), higher insulin resistance index (P=0.001) and triglyceride level (P<0.02), lower HDL level (P=0.001) and more hypertension (P<0.05), but no significant difference in the prevalence of diabetic complications. In conclusion, MODY3 and MODY2 account for only 9 and 1%, respectively, of Chinese MODY. A majority of Chinese MODY patients are due to defects in unknown genes and appear to be characterized by insulin resistance.
引用
收藏
页码:422 / 427
页数:5
相关论文
共 50 条
  • [41] A genetic diagnosis of maturity-onset diabetes of the young (MODY): experiences of patients and family members
    Bosma, A. R.
    Rigter, T.
    Weinreich, S. S.
    Cornel, M. C.
    Henneman, L.
    DIABETIC MEDICINE, 2015, 32 (10) : 1385 - 1392
  • [42] THE COST-EFFECTIVENESS OF GENETIC TESTING FOR MATURITY-ONSET DIABETES OF THE YOUNG
    Naylor, R. N.
    Greeley, S. W.
    Philipson, L. H.
    Bell, G. I.
    John, P. M.
    Huang, E. S.
    Winn, A. N.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2012, 60 (04) : 722 - 723
  • [43] Clinical and genetic features of maturity-onset diabetes of the young in pediatric patients: a 12-year monocentric experience
    Stefano Passanisi
    Giuseppina Salzano
    Bruno Bombaci
    Fortunato Lombardo
    Diabetology & Metabolic Syndrome, 13
  • [44] Cytokine Profile in Patients With Maturity-onset Diabetes of the Young (MODY)
    Diren, Ayca
    Demirci, Deniz Kanca
    Gul, Nurdan
    Karacanli, Burcin
    Baykut, Aykut
    Tutuncu, Yildiz
    Ozturk, Oguz
    Satman, Ilhan
    Yilmaz-aydogan, Hulya
    IN VIVO, 2022, 36 (05): : 2490 - 2504
  • [45] Novel Treatment Options in Patients with Maturity-Onset Diabetes of the Young
    Muessig, Karsten
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2025, 133 (01) : 51 - 58
  • [46] Retinal Imaging Findings in Patients with Maturity-Onset Diabetes of the Young
    Lin, Matthew
    Shah, Jaffer
    Alonso, Laura
    Kiss, Szilard k
    Kovacs, Kyle
    OPHTHALMOLOGY SCIENCE, 2025, 5 (03):
  • [47] Clinical and genetic features of maturity-onset diabetes of the young in pediatric patients: a 12-year monocentric experience
    Passanisi, Stefano
    Salzano, Giuseppina
    Bombaci, Bruno
    Lombardo, Fortunato
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
  • [48] Molecular genetic analyses of Norwegian families with maturity-onset diabetes of the young
    Bjorkhaug, L
    Njolstad, PR
    Thorsby, P
    Lindner, T
    Cockburn, BN
    Molven, A
    Sovik, O
    DIABETOLOGIA, 1999, 42 : A115 - A115
  • [49] Who should have genetic testing for maturity-onset diabetes of the young?
    Naylor, Rochelle
    Philipson, Louis H.
    CLINICAL ENDOCRINOLOGY, 2011, 75 (04) : 422 - 426
  • [50] The genetic spectrum of maturity-onset diabetes of the young in the Lithuanian diabetic population
    Mazgelyte, Egle
    Ambrozaityte, Laima
    Naskauskiene, Gintare
    Tumiene, Birute
    Visockiene, Zydrune
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 166 - 167